Honest Health Lands $140M to Fuel Value-Based Care Revolution

NASHVILLE, TN – February 26, 2026 – In a significant vote of confidence for the future of American healthcare, value-based care enablement company Honest Health today announced it has secured a $140 million capital raise. The investment, led by NewSpring Healthcare, underscores a powerful market momentum away from traditional fee-for-service medicine and toward models that reward better patient outcomes and cost efficiency.

This substantial infusion of capital is earmarked to accelerate Honest Health's expansion into new markets, forge new partnerships with health systems and payers, and enhance its technology-driven platform. The funding round saw strong participation from a syndicate of prominent healthcare investors, including K2 HealthVentures and existing partners Rubicon Founders, Oak HC/FT, Welsh, Carson, Anderson & Stowe (WCAS), and Durable Capital Partners, signaling broad consensus on the company’s potential to reshape healthcare delivery.

Honest Health partners with hospitals and provider groups, equipping them with the technology, data insights, and operational support needed to succeed in value-based arrangements, where payments are tied to quality of care rather than quantity of services. This investment arrives at a critical juncture as health systems nationwide grapple with the complexities of this transition.

The Accelerating Shift to Value

The healthcare industry is in the midst of a seismic shift. For decades, the fee-for-service model has been criticized for incentivizing volume and contributing to unsustainable cost growth. Value-based care (VBC) represents the industry's answer, a paradigm designed to align financial incentives with patient well-being. The market reflects this trend, with projections showing the global value-based healthcare services market expanding from approximately $201 billion in 2023 to over $944 billion by 2032.

This transformation is fueled by pressure from all sides. Government bodies like the Centers for Medicare & Medicaid Services (CMS) are aggressively piloting and scaling VBC models to control federal spending. Meanwhile, employers and private payers are demanding more accountability for the billions they spend on employee health. For providers, however, the transition is fraught with challenges, including significant financial risk, the need for sophisticated data analytics, and a fundamental overhaul of clinical workflows.

This is the complex landscape Honest Health was built to navigate. "Health systems and providers face growing demands to improve outcomes and manage costs, accelerating the need for value-based care models anchored in strong clinical leadership, proven processes, and scalable infrastructure," said Rob Bessler, M.D., chief executive officer of Honest Health.

A Blueprint Built on Clinical and Policy Expertise

What sets Honest Health apart in a competitive field is the deep-seated expertise of its leadership, which combines decades of experience in both scaling physician-led organizations and shaping national healthcare policy.

CEO Rob Bessler, M.D., is the visionary founder of Sound Physicians, which he built from the ground up into a multibillion-dollar, nationwide leader in hospitalist medicine. His success there demonstrated that physician-led groups could be powerful engines for improving quality and efficiency within complex hospital environments. This experience provides Honest Health with a credible, clinician-centric blueprint for engaging doctors and aligning them with the goals of value-based care.

The company was founded in 2021 by Rubicon Founders, an investment firm whose principals include Adam Boehler, the former director of the Center for Medicare and Medicaid Innovation (CMMI). During his tenure, Boehler was a primary architect of influential VBC models that are now foundational to the industry's evolution. This policy-level insight gives Honest Health an unparalleled understanding of the regulatory and payment structures that govern the market.

"Honest Health was created with the conviction that real transformation in healthcare only happens when providers have the tools, accountability and support to focus on value over volume," said Matt Kim, partner at Rubicon Founders. "In a short period of time, the company has demonstrated that belief in action, delivering measurable improvements in patient outcomes, strengthening operational performance and building a more sustainable path forward for providers."

The Investor's $140 Million Bet

The decision by NewSpring Healthcare to lead the $140 million round is a calculated bet on Honest Health's unique combination of leadership, strategy, and market timing. NewSpring has a long track record of backing growth-stage companies that are solving critical problems in the healthcare sector, with a portfolio that includes innovators in value-based oncology care and healthcare IT.

"Value-based care continues to reshape the healthcare landscape, creating significant demand for partners that can support execution at scale," said Mike Kaplan, a NewSpring Partner who will join the Honest Health board. "Honest Health has demonstrated a strong ability to help health systems navigate this transition, and we see substantial opportunity to expand the company's reach. With our deep healthcare operating experience, we're excited to partner with Honest Health to support continued adoption of value-based care and the company's next phase of growth."

The size and composition of the investment syndicate further validate this confidence. The continued backing from firms like Oak HC/FT and WCAS, both seasoned healthcare investors, alongside new capital, suggests a strong belief that Honest Health is not just a participant in the VBC space but a potential leader.

With this new war chest, Honest Health is positioned to aggressively scale its operations. The company plans to use the proceeds to enter new geographic markets, deepen its partnerships with existing health systems, and further develop its technology platform to provide even more actionable insights for clinicians on the front lines. This expansion is not just about growing a business; it's about accelerating a fundamental change in how healthcare is delivered and paid for across the country.